Search Results

There are 18937 results for: content related to: Role of serotonin neurons in the induction of levodopa- and graft-induced dyskinesias in Parkinson's disease

  1. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Version of Record online : 6 JUN 2014, DOI: 10.1002/mds.25914

  2. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  3. You have free access to this content
    l-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson’s disease: temporal and quantitative relationship to the expression of dyskinesia

    Journal of Neurochemistry

    Volume 112, Issue 6, March 2010, Pages: 1465–1476, Hanna S. Lindgren, Daniel R. Andersson, Sören Lagerkvist, Hans Nissbrandt and M. Angela Cenci

    Version of Record online : 24 DEC 2009, DOI: 10.1111/j.1471-4159.2009.06556.x

  4. You have free access to this content
    Poster Session

    Movement Disorders

    Volume 31, Issue S2, June 2016, Pages: S1–S697,

    Version of Record online : 19 JUN 2016, DOI: 10.1002/mds.26688

  5. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Version of Record online : 12 JUN 2015, DOI: 10.1002/mds.26295

  6. You have free access to this content
    Role of striatal l-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats

    Journal of Neurochemistry

    Volume 96, Issue 6, March 2006, Pages: 1718–1727, Manolo Carta, Hanna S. Lindgren, Martin Lundblad, Roberto Stancampiano, Fabio Fadda and M. A. Cenci

    Version of Record online : 3 MAR 2006, DOI: 10.1111/j.1471-4159.2006.03696.x

  7. You have free access to this content
    Proteomic analysis of striatal proteins in the rat model of l-DOPA-induced dyskinesia

    Journal of Neurochemistry

    Volume 102, Issue 4, August 2007, Pages: 1395–1409, Barbara Valastro, Andrzej Dekundy, Morten Krogh, Martin Lundblad, Peter James, Wojciech Danysz, Guenter Quack and Maria Angela Cenci

    Version of Record online : 26 MAY 2007, DOI: 10.1111/j.1471-4159.2007.04655.x

  8. L-DOPA-induced dyskinesia in a rat model of Parkinson's disease is associated with the fluctuational release of norepinephrine in the sensorimotor striatum

    Journal of Neuroscience Research

    Volume 92, Issue 12, December 2014, Pages: 1733–1745, Yong Wang, Hui Sheng Wang, Tao Wang, Chen Huang and Jian Liu

    Version of Record online : 26 JUN 2014, DOI: 10.1002/jnr.23439

  9. You have free access to this content
    Chronic intermittent L-DOPA treatment induces changes in dopamine release

    Journal of Neurochemistry

    Volume 108, Issue 4, February 2009, Pages: 998–1008, Martin Lundblad, Sara Af Bjerkén, M. Angela Cenci, Francois Pomerleau, Greg A. Gerhardt and Ingrid Strömberg

    Version of Record online : 13 DEC 2008, DOI: 10.1111/j.1471-4159.2008.05848.x

  10. L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA

    European Journal of Neuroscience

    Volume 10, Issue 8, August 1998, Pages: 2694–2706, M. A. Cenci, C. S. Lee and A. Björklund

    Version of Record online : 3 FEB 2003, DOI: 10.1046/j.1460-9568.1998.00285.x

  11. You have free access to this content
    Dopamine release from serotonergic nerve fibers is reduced in L-DOPA-induced dyskinesia

    Journal of Neurochemistry

    Volume 118, Issue 1, July 2011, Pages: 12–23, Nina Nevalainen, Sara af Bjerkén, Martin Lundblad, Greg A. Gerhardt and Ingrid Strömberg

    Version of Record online : 25 MAY 2011, DOI: 10.1111/j.1471-4159.2011.07292.x

  12. 2nd World Parkinson Congress Abstracts

    Movement Disorders

    Volume 25, Issue S3, 15 September 2010, Pages: S569–S717,

    Version of Record online : 9 SEP 2010, DOI: 10.1002/mds.23386

    Corrected by:

    Erratum: Erratum

    Vol. 25, Issue 15, 2694, Version of Record online: 10 NOV 2010

  13. Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia

    Movement Disorders

    Volume 28, Issue 8, July 2013, Pages: 1088–1096, Erwan Bezard, Elisabetta Tronci, Elsa Y. Pioli, Qin Li, Gregory Porras, Anders Björklund and Manolo Carta

    Version of Record online : 6 FEB 2013, DOI: 10.1002/mds.25366

  14. Striatal delta opioid receptor binding in experimental models of Parkinson's disease and dyskinesia

    Movement Disorders

    Volume 22, Issue 1, January 2007, Pages: 28–40, Penelope J. Hallett and J.M. Brotchie

    Version of Record online : 6 NOV 2006, DOI: 10.1002/mds.21163

  15. You have free access to this content
    Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels

    Journal of Neurochemistry

    Volume 118, Issue 6, September 2011, Pages: 1043–1055, Simone Bido, Matteo Marti and Michele Morari

    Version of Record online : 5 AUG 2011, DOI: 10.1111/j.1471-4159.2011.07376.x

  16. You have free access to this content
    Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson’s disease

    Journal of Neurochemistry

    Volume 101, Issue 2, April 2007, Pages: 483–497, Flora Mela, Matteo Marti, Andrzej Dekundy, Wojciech Danysz, Michele Morari and M. Angela Cenci

    Version of Record online : 22 JAN 2007, DOI: 10.1111/j.1471-4159.2007.04456.x

  17. Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms

    European Journal of Neuroscience

    Volume 28, Issue 5, September 2008, Pages: 941–950, M. Giorgi, V. D’Angelo, Z. Esposito, V. Nuccetelli, R. Sorge, A. Martorana, A. Stefani, G. Bernardi and G. Sancesario

    Version of Record online : 20 AUG 2008, DOI: 10.1111/j.1460-9568.2008.06387.x

  18. You have free access to this content
    The α2 adrenoceptor antagonist idazoxan alleviates l-DOPA-induced dyskinesia by reduction of striatal dopamine levels: an in vivo microdialysis study in 6-hydroxydopamine-lesioned rats

    Journal of Neurochemistry

    Volume 112, Issue 2, January 2010, Pages: 444–452, Kerstin Buck, Patrizia Voehringer and Boris Ferger

    Version of Record online : 6 NOV 2009, DOI: 10.1111/j.1471-4159.2009.06482.x

  19. Chronic high-frequency stimulation of the subthalamic nucleus and L-DOPA treatment in experimental parkinsonism: effects on motor behaviour and striatal glutamate transmission

    European Journal of Neuroscience

    Volume 24, Issue 6, September 2006, Pages: 1802–1814, Paolo Gubellini, Alexandre Eusebio, Abid Oueslati, Christophe Melon, Lydia Kerkerian-Le Goff and Pascal Salin

    Version of Record online : 21 SEP 2006, DOI: 10.1111/j.1460-9568.2006.05047.x

  20. Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: Evidence from the effects of the alpha2 adrenoceptor antagonist idazoxan

    Movement Disorders

    Volume 16, Issue 4, July 2001, Pages: 642–650, Susan H. Fox, Brian Henry, Micheal P. Hill, David Peggs, Alan R. Crossman and Jonathan M. Brotchie

    Version of Record online : 16 JUL 2001, DOI: 10.1002/mds.1148